3004 90 92 40

Code

3004 90 92 40

Type

10-digit tariff line

Duty rate

Free (set at subheading 30049092)

Unit

kg

Classification rulings (U.S. Customs, CROSS)

• N357497 · 2026-02-03 — The tariff classification of Elinzanetant (CAS No. 929046-33-3) in bulk form and LYNKUET® (E linzanetant) Capsules in dosage form, from Germany

  Elinzanetant is a neurokinin 1 (NK1) and neurokinin 3 (NK3) receptor antagonist that acts on the central nervous system (CNS). It is indicated for the treatment of moderate to severe vasomotor symptoms (VMS; also known as hot flashes) associated with menopause or endocrine therapy (ET) for breast cancer. Lynkuet, imported in 60 mg capsule form, is a neurokinin 1 (NK1) and neurokinin 3 (NK3) receptor antagonist. It is indicated as an alternative to hormonal replacement therapy for women who cannot use hormone-based treatments for the treatment of moderate to severe vasomotor symptoms, commonly…

• N351756 · 2025-08-27 — The tariff classification of Carbidopa and Levodopa Extended-Release Capsules in dosage form, from India

  Carbidopa and Levodopa, imported in 23.75/95 mg, 36.25/145 mg, 48.75/195 mg and 61.25/245 mg capsules, is a combination medication containing Carbidopa and Levodopa as the active ingredients. It is indicated for the treatment of Parkinson’s disease, post encephalitic parkinsonism and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. The applicable subheading for the Carbidopa and Levodopa Extended-Release Capsules in dosage form will be 3004.90.9240, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments ……

• N340583 · 2024-07-03 — The tariff classification of Cyclobenzaprine Hydrochloride Tablets in dosage form, from India

  Cyclobenzaprine Hydrochloride, imported in 5 mg, 7.5 mg and 10 mg tablets, is a skeletal muscle relaxant that works on the brainstem to treat muscle spasms of local origin. It is indicated as a short-term (2-3 weeks) adjunct therapy, along with rest and physical therapy, for the relief of muscle spasms associated with acute, painful musculoskeletal conditions. The applicable subheading for the Cyclobenzaprine Hydrochloride Tablets in dosage form will be 3004.90.9240, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed…

• N338528 · 2024-03-18 — The tariff classification off Edaravone Injection in dosage form, from India

  Edaravone Injection, imported in 30 mg/100 mL (0.3 mg/mL), is a free radical scavenger and neuroprotective agent with antioxidant properties. It is indicated for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a neurological disorder that affects motor neurons. The applicable subheading for the Edaravone Injection in dosage form will be 3004.90.9240, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in…

• N333935 · 2023-07-28 — The tariff classification of Balsalazide Disodium Capsules USP and Carbidopa Tablets in dosage form, from Taiwan and India, respectively

  Balsalazide Disodium, imported in 750 mg capsules, is an anti-inflammatory drug that is indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. In your letter, you stated Balsalazide Disodium capsules will be imported from India. Carbidopa, imported in 25 mg tablets, is in a class of medications called decarboxylase inhibitors. It is indicated for use with carbidopa-levodopa or with levodopa in the treatment of the symptoms of idiopathic Parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic…

• 3004 90 92 20 — Other: — Cardiovascular medicaments: — Containing amiodarone or its salts
• 3004 90 92 21 — Other: — Cardiovascular medicaments: — Containing diltiazem or its salts
• 3004 90 92 22 — Other: — Cardiovascular medicaments: — Containing hydralazine or its salts
• 3004 90 92 23 — Other: — Cardiovascular medicaments: — Containing enoxaparin or its salts
• 3004 90 92 24 — Other: — Cardiovascular medicaments: — Containing labetalol or its salts
• 3004 90 92 25 — Other: — Cardiovascular medicaments: — Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts
• 3004 90 92 26 — Other: — Cardiovascular medicaments: — Other
• 3004 90 92 27 — Other: — Medicaments primarily affecting the central nervous system: — Analgesics, antipyretics and nonhormonal anti-inflammatory agents: — Tolmetin
• 3004 90 92 28 — Other: — Medicaments primarily affecting the central nervous system: — Analgesics, antipyretics and nonhormonal anti-inflammatory agents: — Tolmetin sodium…
• 3004 90 92 29 — Other: — Medicaments primarily affecting the central nervous system: — Analgesics, antipyretics and nonhormonal anti-inflammatory agents: — Tolmetin sodium…
• 3004 90 92 30 — Other: — Medicaments primarily affecting the central nervous system: — Analgesics, antipyretics and nonhormonal anti-inflammatory agents: — Containing…
• 3004 90 92 31 — Other: — Medicaments primarily affecting the central nervous system: — Analgesics, antipyretics and nonhormonal anti-inflammatory agents: — Containing…
• 3004 90 92 32 — Other: — Medicaments primarily affecting the central nervous system: — Analgesics, antipyretics and nonhormonal anti-inflammatory agents: — Containing…
• 3004 90 92 33 — Other: — Medicaments primarily affecting the central nervous system: — Analgesics, antipyretics and nonhormonal anti-inflammatory agents: — Containing…
• 3004 90 92 34 — Other: — Medicaments primarily affecting the central nervous system: — Analgesics, antipyretics and nonhormonal anti-inflammatory agents: — Containing…
• 3004 90 92 35 — Other: — Medicaments primarily affecting the central nervous system: — Analgesics, antipyretics and nonhormonal anti-inflammatory agents: — Containing tramadol
• 3004 90 92 36 — Other: — Medicaments primarily affecting the central nervous system: — Analgesics, antipyretics and nonhormonal anti-inflammatory agents: — Other
• 3004 90 92 37 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing dexmedetomidine, etomidate,…
• 3004 90 92 38 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing midazolam or its salts
• 3004 90 92 39 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing phenytoin or its salts
• 3004 90 92 41 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing levetiracetam, phenytoin or their…
• 3004 90 92 42 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Containing etomidate or its salts
• 3004 90 92 43 — Other: — Medicaments primarily affecting the central nervous system: — Anticonvulsants, hypnotics and sedatives: — Other
• 3004 90 92 44 — Other: — Medicaments primarily affecting the central nervous system: — Antidepressants, tranquilizers, and other psychotherapeutic agents: — Containing…
• 3004 90 92 45 — Other: — Medicaments primarily affecting the central nervous system: — Antidepressants, tranquilizers, and other psychotherapeutic agents: — Containing…
• 3004 90 92 46 — Other: — Medicaments primarily affecting the central nervous system: — Antidepressants, tranquilizers, and other psychotherapeutic agents: — Other
• 3004 90 92 47 — Other: — Medicaments primarily affecting the central nervous system: — Other: — Containing rocuronium or its salts
• 3004 90 92 48 — Other: — Medicaments primarily affecting the central nervous system: — Other: — Containing succinylcholine or its salts
• 3004 90 92 49 — Other: — Medicaments primarily affecting the central nervous system: — Other: — Other
• 3004 90 92 50 — Other: — Dermatological agents and local anesthetics: — Containing lidocaine or its salts
• 3004 90 92 51 — Other: — Dermatological agents and local anesthetics: — Other
• 3004 90 92 52 — Other: — Medicaments primarily affecting the digestive system: — Laxatives
• 3004 90 92 53 — Other: — Medicaments primarily affecting the digestive system: — Antacids
• 3004 90 92 54 — Other: — Medicaments primarily affecting the digestive system: — Containing famotidine or its salts
• 3004 90 92 55 — Other: — Medicaments primarily affecting the digestive system: — Containing pantoprazole or its salts
• 3004 90 92 56 — Other: — Medicaments primarily affecting the digestive system: — Containing ondansetron or its salts
• 3004 90 92 57 — Other: — Medicaments primarily affecting the digestive system: — Containing glycopyrrolate or its salts
• 3004 90 92 58 — Other: — Medicaments primarily affecting the digestive system: — Containing loperamide or its salts
• 3004 90 92 60 — Other: — Medicaments primarily affecting the digestive system: — Other
• 3004 90 92 61 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Diuretics: — Containing furosemide and its salts

• 30049 — ТН ВЭД ЕАЭС: прочие:
• 300490 — EU CN/TARIC: Other

Related news

• FMC proposes $200,000 fee on Spanish-flag ships and curbs on Spanish imports
• BIS details zero-tariff drug categories ahead of September 29 tariff

Not sure this code fits your product? HaiLang AI determines the US HTS code from a description in about a minute.